Skip to content

Clinical trials

Squamous Cell Carcinoma of Head and Neck trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Country / region: France Clear all

208 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20052
20061
20074
20085
20097
20106
20115
20126
20136
20148
201510
20165
201712
201813
201912
202015
202118
202211
202314
202419
202510
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Recruiting36
Active, not recruiting34
Terminated33
Unknown status10
Not yet recruiting5
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Groupe Oncologie Radiotherapie Tete et Cou21
UNICANCER11
Centre Leon Berard8
European Organisation for Research and Treatment of Cancer - EORTC7
GlaxoSmithKline6
AbbVie5
Centre Henri Becquerel5
Gustave Roussy, Cancer Campus, Grand Paris5
Merck Sharp & Dohme LLC5
Novartis Pharmaceuticals5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck208
Head and Neck Neoplasms48
Carcinoma, Non-Small-Cell Lung31
Melanoma21
Colorectal Neoplasms20
Neoplasm Metastasis19
Neoplasms17
Recurrence17
Uterine Cervical Neoplasms16
Triple Negative Breast Neoplasms15

Trials

Showing 76 to 100 of 208. Each trial links to its page on Pharma Observatory.

108 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.